{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:27:49Z","timestamp":1790864869302,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/hjh.0b013e32833c20eb","type":"journal-article","created":{"date-parts":[[2010,6,24]],"date-time":"2010-06-24T05:47:18Z","timestamp":1277358438000},"page":"1928-1934","source":"Crossref","is-referenced-by-count":34,"title":["Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity"],"prefix":"10.1097","volume":"28","author":[{"given":"Inge HHT","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alferso C","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"van Ede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Liam","family":"Oey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Ligtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Blankestijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210208","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"R2-21-20210208","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"R3-21-20210208","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"Am J Transplant"},{"key":"R4-21-20210208","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1681\/ASN.V122368","article-title":"Cardiovascular risk factors in renal transplant patients: cyclosporin A versus tacrolimus","volume":"12","author":"Ligtenberg","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R5-21-20210208","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1097\/01.ASN.0000071515.27754.67","article-title":"Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus","volume":"14","author":"Artz","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R6-21-20210208","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.healun.2004.03.008","article-title":"Calcineurin inhibitors in heart transplantation","volume":"23","author":"Keogh","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R7-21-20210208","first-page":"1110","article-title":"The U.S. Multicenter FK506 Liver Study Group.","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"R8-21-20210208","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.transproceed.2007.03.014","article-title":"Low-dose versus high-dose cyclosporine induction protocols in renal transplantation","volume":"39","author":"Ghafari","year":"2007","journal-title":"Transplant Proc"},{"key":"R9-21-20210208","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.transproceed.2009.06.152","article-title":"Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study","volume":"41","author":"Beckebaum","year":"2009","journal-title":"Transplant Proc"},{"key":"R10-21-20210208","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199009133231101","article-title":"Cyclosporine-induced sympathetic activation and hypertension after heart transplantation","volume":"323","author":"Scherrer","year":"1990","journal-title":"N Engl J Med"},{"key":"R11-21-20210208","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/01.hjh.0000222767.15100.e4","article-title":"Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine","volume":"24","author":"Hausberg","year":"2006","journal-title":"J Hypertens"},{"key":"R12-21-20210208","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.CIR.88.3.1101","article-title":"Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation","volume":"88","author":"Kaye","year":"1993","journal-title":"Circulation"},{"key":"R13-21-20210208","first-page":"516","article-title":"Normalization of total body and regional sympathetic hyperactivity in heart failure after heart transplantation","volume":"15","author":"Rundqvist","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"R14-21-20210208","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.73.3.596","article-title":"Cyclosporine-and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling","volume":"73","author":"Lyson","year":"1993","journal-title":"Circ Res"},{"key":"R15-21-20210208","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/jlts.2000.9737","article-title":"Posttransplantation hypertension related to calcineurin inhibitors","volume":"6","author":"Textor","year":"2000","journal-title":"Liver Transpl"},{"key":"R16-21-20210208","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1432-2277.2005.00080.x","article-title":"Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine","volume":"18","author":"Jardine","year":"2005","journal-title":"Transpl Int"},{"key":"R17-21-20210208","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-201X.1968.tb10904.x","article-title":"Pulse and respiratory grouping of sympathetic impulses in human muscle-nerves","volume":"74","author":"Hagbarth","year":"1968","journal-title":"Acta Physiol Scand"},{"key":"R18-21-20210208","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.95.9.2271","article-title":"Cold stress provokes sympathoinhibitory presyncope in healthy subjects and hemodialysis patients with low cardiac output","volume":"95","author":"Ligtenberg","year":"1997","journal-title":"Circulation"},{"key":"R19-21-20210208","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/clinchem\/31.1.149","article-title":"Confirmation of the optimal pH for measuring renin activity in plasma","volume":"31","author":"Boer","year":"1985","journal-title":"Clin Chem"},{"key":"R20-21-20210208","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/clinchem\/29.1.180","article-title":"Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay","volume":"29","author":"Carruthers","year":"1983","journal-title":"Clin Chem"},{"key":"R21-21-20210208","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00004872-199311000-00008","article-title":"Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man","volume":"11","author":"Sturrock","year":"1993","journal-title":"J Hypertens"},{"key":"R22-21-20210208","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00004872-199506000-00014","article-title":"Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males","volume":"13","author":"Sturrock","year":"1995","journal-title":"J Hypertens"},{"key":"R23-21-20210208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00004872-199715030-00014","article-title":"Cyclosporine-induced hypertension and decline in renal function in healthy volunteers","volume":"15","author":"Hansen","year":"1997","journal-title":"J Hypertens"},{"key":"R24-21-20210208","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00007890-200203150-00012","article-title":"Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects","volume":"73","author":"Klein","year":"2002","journal-title":"Transplantation"},{"key":"R25-21-20210208","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ki.1995.200","article-title":"Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation","volume":"47","author":"Textor","year":"1995","journal-title":"Kidney Int"},{"key":"R26-21-20210208","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1681\/ASN.V5111910","article-title":"Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation","volume":"5","author":"Canzanello","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R27-21-20210208","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","article-title":"Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2)","volume":"22","author":"Esteva-Font","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R28-21-20210208","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(87)90497-9","article-title":"Suppression of plasma renin activity by cyclosporine","volume":"83","author":"Bantle","year":"1987","journal-title":"Am J Med"},{"key":"R29-21-20210208","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.HYP.26.4.705","article-title":"Cyclosporine impairs vasodilation without increased sympathetic activity in humans","volume":"26","author":"Stein","year":"1995","journal-title":"Hypertension"},{"key":"R30-21-20210208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.HYP.34.1.102","article-title":"Role of sympathetic nervous system in cyclosporine-induced rise in blood pressure","volume":"34","author":"Carvalho","year":"1999","journal-title":"Hypertension"},{"key":"R31-21-20210208","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg","year":"2002","journal-title":"Circulation"},{"key":"R32-21-20210208","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.HYP.34.4.752","article-title":"Importance of glycinergic and glutamatergic synapses within the rostral ventrolateral medulla for blood pressure regulation in conscious rats","volume":"34","author":"Araujo","year":"1999","journal-title":"Hypertension"},{"key":"R33-21-20210208","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1291\/hypres.23.633","article-title":"Cardiovascular and sympathetic effects of L-glutamate and glycine injected into the rostral ventrolateral medulla of conscious rats","volume":"23","author":"Sakima","year":"2000","journal-title":"Hypertens Res"},{"key":"R34-21-20210208","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1073\/pnas.92.14.6269","article-title":"Presynaptic modulation of cortical synaptic activity by calcineurin","volume":"92","author":"Victor","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R35-21-20210208","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0895-7061(00)00288-0","article-title":"Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension","volume":"13","author":"Zhang","year":"2000","journal-title":"Am J Hypertens"},{"key":"R36-21-20210208","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.170160397","article-title":"Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R37-21-20210208","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.RES.57.5.676","article-title":"Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat","volume":"57","author":"Faber","year":"1985","journal-title":"Circ Res"},{"key":"R38-21-20210208","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.TP.0000121196.71904.E0","article-title":"Oral cyclosporine but not tacrolimus reduces renal transplant blood flow","volume":"77","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"R39-21-20210208","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s004670100659","article-title":"Renal hemodynamic effect of tacrolimus in renal transplanted children","volume":"16","author":"Dello Strologo","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"R40-21-20210208","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.bjp.0705659","article-title":"Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats","volume":"141","author":"Gardiner","year":"2004","journal-title":"Br J Pharmacol"},{"key":"R41-21-20210208","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1042\/cs0920285","article-title":"Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man","volume":"92","author":"Grassi","year":"1997","journal-title":"Clin Sci (Lond)"},{"key":"R42-21-20210208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01826234","article-title":"Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade","volume":"3","author":"Fagius","year":"1993","journal-title":"Clin Auton Res"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201009000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:29:53Z","timestamp":1786040993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201009000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32833c20eb","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}